Patent details
EP4062912 Title: UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD THEREFOR AND USE THEREOF
Basic Information
- Publication number:
- EP4062912
- PCT Application Number:
- CN2021085903
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217837665
- PCT Publication Number:
- WO2021204188
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD THEREFOR AND USE THEREOF
- French Title of Invention:
- MONOCRISTAL SEMI-HYDRATÉ D'UTIDÉLONE ET SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
- German Title of Invention:
- HALBHYDRIERTER UTIDELON-EINKRISTALL UND VERFAHREN ZU SEINER HERSTELLUNG UND SEINE VERWENDUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 03/04/2024
- Unitary Effect Registration Date:
- 06/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 08/04/2021
- Grant date:
- 03/04/2024
- EP Publication Date:
- 28/09/2022
- PCT Publication Date:
- 14/10/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/04/2024
- EP B1 Publication Date:
- 03/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/04/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/03/2024
- Name:
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Address:
- Suite 310, Building 3 No. 88 Kechuang 6th Street, Beijing 101111, China (CN)
- Name:
- CHENGDU BIOSTAR PHARMACEUTICALS, LTD.
- Address:
- No. 308 Kang Qiang 2nd Road Chengdu High Technology Zone Chengdu, Sichuan 611730, China (CN)
Inventor
1
- Name:
- TANG, Li
- Address:
- China (CN)
2
- Name:
- KONG, Rixiang
- Address:
- China (CN)
3
- Name:
- QIU, Rongguo
- Address:
- China (CN)
Priority
- Priority Number:
- 202010282801
- Priority Date:
- 08/04/2020
- Priority Country:
- China (CN)
Classification
- IPC classification:
- C07D 417/06; A61P 35/00; A61K 31/427;
Publication
European Patent Bulletin
1
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|